Blood pressure lowering effect of korea ginseng derived ginseol K-g1

American Journal of Chinese Medicine

Volumn 42, Issue 3, 2014, Pages 605-618

  Rhee, Moo Yong ^a   Cho, Belong ^b   Kim, Kwang Il ^b,c   Kim, Joohee ^d   Kim, Mi Kyung ^e   Lee, Eun Kyung ^d   Kim, Hye Jin ^f   Kim, Cheol Ho ^b,c  

^a Dongguk University Ilsan Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Ewha Womans University   (South Korea)

^e Biofood CRO Co Ltd   (South Korea)

^f CJ Corporation   (South Korea)

Author keywords

Blood Pressure; Clinical Trial; Ginseng; Ginseol K g1

Indexed keywords

GINSENG EXTRACT; GINSENOSIDE; GINSEOL K G1; PROTOPANAXATRIOL; UNCLASSIFIED DRUG; ANTIHYPERTENSIVE AGENT; GINSEOL K-G1;

ADULT; ALTERNATIVE MEDICINE; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITOR; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG SAFETY; FACE; FEMALE; FLUSHING; GASTROINTESTINAL SYMPTOM; GINSENG; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MULTICENTER STUDY; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; AGED; CHEMISTRY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECTS; ISOLATION AND PURIFICATION; MIDDLE AGED; PANAX; PATHOPHYSIOLOGY; PHYTOTHERAPY; TIME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GINSENOSIDES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PANAX; PHYTOTHERAPY; TIME FACTORS;

EID: 84901779583     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X14500396     Document Type: Article

References (25)

1. Ahn, H.Y., S.Y. Hong, J.Y. Kim and O. Kwon. Panax ginseng extract rich in ginsenoside protopanaxatriol offers combinatorial effects in nitric oxide production via multiple signaling pathways. Springerplus 2: 96, 2013.
2. Attele, A.S., J.A. Wu and C.S. Yuan. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol. 58: 1685-1693, 1999.
3. Chen, H., J. Yin, Y. Deng, M. Yang, L. Xu, F. Teng, D. Li, Y. Cheng, S. Liu, D. Wang, T. Zhang, W. Wu, X. Liu, S. Guan, B. Jiang and D. Guo. The protective effects of ginsenoside Rg1 against hypertension target-organ damage in spontaneously hypertensive rats. BMC Complement. Alternat. Med. 12: 53, 2012.
4. Christensen, L.P. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv. Food Nutr. Res. 55: 1-99, 2009.
5. Gillis, C.N. Panax ginseng pharmacology: A nitric oxide link? Biochem. Pharmacol. 54: 1-8, 1997. (Pubitemid 27353216)
6. Guo, J., X.T. Gan, J.V. Haist, V. Rajapurohitam, A. Zeidan, N.S. Faruq and M. Karmazyn. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation. Circ. Heart Fail. 4: 79-88, 2011.
7. Han, K.H., S.C. Choe, H.S. Kim, D.W. Sohn, K.Y. Nam, B.H. Oh, M.M. Lee, Y.B. Park, Y.S. Choi, J.D. Seo and Y.W. Lee. Effect of red ginseng on blood pressure in patients with essential hypertension and white coat hypertension. Am. J. Chin. Med. 26: 199-209, 1998.
8. Hong, S.Y., J.Y. Kim, H.Y. Ahn, J.H. Shin and O. Kwon. Panax ginseng extract rich in ginsenoside protopanaxatriol attenuates blood pressure elevation in spontaneously hypertensive rats by affecting the Akt-dependent phosphorylation of endothelial nitric oxide synthase. J. Agric. Food Chem. 60: 3086-3091, 2012.
9. Hwang, J.W., J.H. Oh, H.S. Yoo, Y.W. Lee, C.K. Cho, K.R. Kwon, J.H. Yoon, J. Park, S. Her, Z.W. Lee, I.S. Jang and J.S. Choi. Mountain ginseng extract exhibits anti-lung cancer activity by inhibiting the nuclear translocation of NF-kappaB. Am. J. Chin. Med. 40: 187-202, 2012.
10. Jovanovski, E., A. Jenkins, A.G. Dias, V. Peeva, J. Sievenpiper, J.T. Arnason, D. Rahelic, R.G. Josse and V. Vuksan. Effects of Korean red ginseng (Panax ginseng C.A. Mayer) and its isolated ginsenosides and polysaccharides on arterial stiffness in healthy individuals. Am. J. Hypertens. 23: 469-472, 2010.
11. Kaku, T., T. Miyata, T. Uruno, I. Sako and A. Kinoshita. Chemico-pharmacological studies on saponins of Panax ginseng C. A. Meyer. I. Chemical part. Arzneimittel-Forschung 25: 343-347, 1975.
12. Kang, S.Y., V.B. Schini-Kerth and N.D. Kim. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta. Life Sci. 56: 1577-1586, 1995.
13. Karmazyn, M., M. Moey and X.T. Gan. Therapeutic potential of Ginseng in the management of cardiovascular disorders. Drugs 71: 1989-2008, 2011.
14. Kim, N.D., E.M. Kim, K.W. Kang, M.K. Cho, S.Y. Choi and S.G. Kim. Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase. Br. J. Pharmacol. 140: 661-670, 2003.
15. Leung, K.W., Y.L. Pon, R.N. Wong and A.S. Wong. Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and beta-catenin/T-cell factor-dependent pathway in human endothelial cells. J. Biol. Chem. 281: 36280-36288, 2006.
16. Leung, K.W. and A.S. Wong. Pharmacology of ginsenosides: A literature review. Chin. Med. 5: 20, 2010.
17. Miller, L.G. Herbal medicinals: Selected clinical considerations focusing on known or potential drug-herb interactions. Arch. Intern. Med. 158: 2200-2211, 1998.
18. Park, B.J., Y.J. Lee, H.R. Lee, D.H. Jung, H.Y. Na, H.B. Kim and J.Y. Shim. Effects of Korean Red Ginseng on cardiovascular risks in subjects with metabolic syndrome: A double-blind randomized controlled study. Kor. J. Fam. Med. 33: 190-196, 2012.
19. Pickering, T.G., J.E. Hall, L.J. Appel, B.E. Falkner, J. Graves, M.N. Hill, D.W. Jones, T. Kurtz, S.G. Sheps and E.J. Roccella. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 111: 697-716, 2005.
20. Shergis, J.L., A.L. Zhang, W. Zhou and C.C. Xue. Quality and risk of bias in Panax ginseng randomized controlled trials: A review. Am. J. Chin. Med. 41: 231-252, 2013.
21. Siegel, R.K. Ginseng and high blood pressure. JAMA 243: 32, 1980.
22. Stavro, P.M., M. Woo, T.F. Heim, L.A. Leiter and V. Vuksan. North American ginseng exerts a neutral effect on blood pressure in individuals with hypertension. Hypertens 46: 406-411, 2005. (Pubitemid 41099177)
23. Sung, J., K.H. Han, J.H. Zo, H.J. Park, C.H. Kim and B.H. Oh. Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. Am. J. Chin. Med. 28: 205-216, 2000.
24. Yamashina, A., H. Tomiyama, K. Takeda, H. Tsuda, T. Arai, K. Hirose, Y. Koji, S. Hori and Y. Yamamoto. Validity, reproducibility, and clinical significance of noninvasive brachialankle pulse wave velocity measurement. Hypertens. Res. 25: 359-364, 2002.
25. Yun, T.K. Panax ginseng-A non-organ-specific cancer preventive? Lancet Oncol. 2: 49-55, 2001.